Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New cephem antibacterial agents from Takeda

Jan. 30, 1997

Schering-Plough claims tetrahydrofuran antifungal agents

Jan. 30, 1997

SKB reports novel camptothecin analogues

Jan. 30, 1997

New ropinirole formulation described by SKB

Jan. 29, 1997

Lilly claims new indications for olanzapine

Jan. 29, 1997

New use claimed for maprotiline

Jan. 29, 1997

Dual COX-2/5-LO inhibitors reported by Searle

Jan. 29, 1997

Japanese researchers isolate novel ACAT inhibitor

Jan. 29, 1997

Antiulcer agents from Otsuka

Jan. 29, 1997

Banyu prepares selective muscarinic antagonists with reduced side effects

Jan. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.